Heart Test Laboratories, Inc. Stock
Equities
HSCS
US42254E3027
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.42 USD | -7.89% | -10.36% | -62.99% |
Financials (USD)
Sales 2024 * | 59.3K | Sales 2025 * | 1.9M | Capitalization | 4.57M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -9M | EV / Sales 2024 * | 77.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.41 x |
P/E ratio 2024 * |
-0.35
x | P/E ratio 2025 * |
-0.66
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.99% |
1 day | -8.32% | ||
1 week | -20.80% | ||
Current month | -24.57% | ||
1 month | -30.37% | ||
3 months | -44.99% | ||
6 months | -57.94% | ||
Current year | -59.24% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Danielle Watson
DFI | Director of Finance/CFO | 42 | 21-10-31 |
Aaron Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Hilz
COO | Chief Operating Officer | 66 | 13-07-24 |
David R. Wells
BRD | Director/Board Member | 61 | 22-12-27 |
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 6.31 | -9.47% | 77 645 |
24-05-17 | 6.97 | -38.37% | 348,902 |
24-05-16 | 11.31 | +25.81% | 411,195 |
24-05-15 | 8.99 | +13.65% | 74,210 |
24-05-14 | 7.91 | +12.04% | 31,975 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.24% | 4.57M | |
-11.41% | 2.95B | |
-14.72% | 84.22M | |
+8.70% | 53.05M |
- Stock Market
- Equities
- HSCS Stock